SAB Biotherapeutics | Results Presentation Deck | 12 slides

SAB Biotherapeutics · 2022-09
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

1
coverage by narrative range · generated from this deck JSON
Narrative range 12 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Whole deck 12 slides 100% 12/12 slides 100% 12/12 slides · 59 hits
0/12 slides
66.7% 8/12 slides · 10 hits 25% 3/12 slides
0/12 slides
0/12 slides

Slide inventory

12
every slide · same image gating as the playbook
01
Slide 1
Includes exhibit number and presenter credentials.front_matter
02
Page number 2 in the top right corner.front_matter
03
establish_context
04
The slide uses a process flow diagram to explain a proprietary biotechnology manufacturing method.present_framework
05
The table uses color coding to distinguish between vaccine strains (green) and non-vaccine strains (blue).compare_peers
06
Details the study sponsorship, location, participant demographics, dosing, and timeline.establish_context
07
Clinical trial design disclosure.summarize
08
Standard CONSORT-style participant flow diagram.summarize
09
The slide presents two line charts comparing treatment and placebo groups over time relative to viral challenge.analyze_data
10
The chart shows a clear separation between the treatment and placebo groups, indicating faster viral clearance in the treatment arm.analyze_data
11
summarize